Tumors can produce bioactive substances called tumor-derived supernatants (TDS) that modify the immune response in the host body. This can result in immunosuppressive effects that promote the growth and spread of cancer.
Sajjad Ahmadpour+5 more
doaj
Elucidation of Mechanisms by Which Microplastics (PET) Facilitates the Rapid Growth of Benthic Cyanobacteria and Toxin Production in Aquatic Ecosystems. [PDF]
Mir R+12 more
europepmc +1 more source
2-Chloroethyl Trimethylammonium Chloride and Related Compounds as Plant Growth Substances. V. Growth, Flowering, and Fruiting Responses as Related to Those Induced by Auxin and Gibberellin [PDF]
S. H. Wittwer, N. E. Tolbert
openalex +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi+12 more
wiley +1 more source
The effects of different light qualities on the growth and nutritional components of <i>Pleurotus citrinopileatus</i>. [PDF]
Chen X+6 more
europepmc +1 more source
Growth-promoting and Growth-inhibiting Substances in the Petiole
Yasuyuki Okabe
openalex +2 more sources
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza+3 more
wiley +1 more source
Exploring Microbial Ecosystem Services for Environmental Stress Amelioration: A Review. [PDF]
Semwal P+5 more
europepmc +1 more source
Vigorous Mold Growth in Soils After Addition of Water-Insoluble Fatty Substances [PDF]
Frank P. Krause, Willy Lange
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source